This report will be a detailed market and technology assessment and forecast of the products and technologies in the clinical management of obesity. The report will describe the current and projected patient population in obesity, detailing their incidence worldwide, the clinical practices in their management to encompass surgical approaches, medical supervised severely restricted diets, drug therapies, OTC treatments, biopharmaceuticals, non-pharmacologic approaches and weight maintenance approaches.
The report will describe clinical trends in the management of the obese. The report will detail the products on the market and the status of those in development for bariatric surgery, drug therapy, gastric stimulation devices, brain stimulation devices, combination therapies and genetic therapy, and will provide current and forecast of the market for these products in the U.S. and separately for Europe. The report will profile at least 25 companies in this market, detailing the current products, products in development, market position and overall businesses in obesity management.